2 Top Stocks Down 40% to Buy With $1,000
If you have $1,000 you don't need for at least five years, there are a few growth stocks that Wall Street is currently sleeping on that could deliver great returns over the next few years.
1. Reddit
Reddit (NYSE: RDDT) is a popular online platform that is built around discussion threads on an endless number of topics. Over 400 million people visit Reddit on a weekly basis. This has driven strong growth in the company's advertising revenue, which is the primary means it monetizes its platform.
The stock is down 39% from its recent highs. This can be attributed to two things. First, it was due for a correction after climbing to a high price-to-sales multiple of around 25. It now trades at a lower multiple of 19.
Second, Wall Street has been concerned about Alphabet 's Google's launch of new artificial intelligence (AI) features in Search. Google's AI Overviews, for example, is taking content from Reddit and summarizing it in Google Search results. This could lead to less traffic going directly to Reddit's platform and limit its revenue growth prospects.
However, Reddit continued to report extremely strong growth in the first quarter. Revenue grew 61% year over year, with 108 million daily active users. Advertisers continue to invest in Reddit's platform, given the high engagement from these users, not to mention that many people visiting Reddit are researching a product to buy, making it more likely they will click on an ad.
All the discussions and comments across Reddit's communities are not only leading to strong advertising growth, but also opening up new growth opportunities. In fact, Reddit is starting to make a significant amount of money licensing its data to companies building AI models. Its "other" revenue grew 66% year over year in Q1, representing about 9% of its quarterly revenue.
This growth in data licensing signals a competitive advantage for Reddit not fully reflected in the stock price. This makes the stock a compelling buy after the recent dip.
2. Marvell Technology
There is substantial investment pouring into data center infrastructure (e.g., advanced chips and networking systems) to lay the groundwork for an AI-driven economy. Marvell Technology (NASDAQ: MRVL) is riding this wave, yet the stock is down 41% from its recent high, setting up a buying opportunity ahead of a potential bull run.
Marvell is a leader in supplying custom chip solutions and networking products for data centers. Its data center business totaled 76% of its revenue last quarter and also, coincidentally, grew 76% year over year.
The chipmaker has benefited greatly from its partnership with Amazon Web Services, the leading cloud services provider for enterprises. In late 2024, it signed a new five-year deal to supply AWS with custom AI chips and networking products, which are needed for faster data transfer in AI workloads.
Marvell also has a partnership with Nvidia to integrate its chips in Nvidia's NVLink Fusion. NVLink is a game-changing product that brings together custom chip solutions from multiple suppliers on a single platform. This could spell more demand for Marvell's accelerator processing units (XPUs).
These agreements with AWS and Nvidia significantly bolster Marvell's long-term prospects. The stock looks expensive, trading at high multiples of sales and earnings. But keep in mind that it is seeing margins improve from growing demand.
Adjusted earnings more than doubled year over year to $0.62 in the first quarter. Wall Street analysts expect 46% annualized earnings growth over the next few years, which could support significant upside in the stock.
Should you invest $1,000 in Reddit right now?
Before you buy stock in Reddit, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Reddit wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $713,547!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $966,931!*
Now, it's worth noting Stock Advisor 's total average return is1,062% — a market-crushing outperformance compared to177%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of June 23, 2025
John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. John Ballard has positions in Nvidia. The Motley Fool has positions in and recommends Alphabet, Amazon, and Nvidia. The Motley Fool recommends Marvell Technology. The Motley Fool has a disclosure policy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
23 minutes ago
- Globe and Mail
Should You Buy Nvidia Stock Before Aug. 27? Here's What the Evidence Suggests.
Key Points After more than two years of phenomenal gains, investors are wary about the future of AI. Nvidia's GPUs are a staple in the AI revolution, and sales continue at a brisk pace. There's a growing body of evidence that suggests Nvidia's epic run will continue, as will the stocks volatility. 10 stocks we like better than Nvidia › The dawn of artificial intelligence (AI) in late 2022 has had a profound impact on the technology landscape. The initial fervor has since died down, and investors are looking for compelling evidence that the adoption of AI has room to run. Nvidia (NASDAQ: NVDA) graphics processing units (GPUs) were widely adopted and have become the gold standard for generative AI. The company is scheduled to release the results of its fiscal 2026 second quarter after the market closes on Wednesday, Aug. 27, and Wall Street and shareholders alike will be sitting on the edge of their seats looking for clues that strong demand for AI chips continues. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Let's look at the company's most recent results, what current events suggest about the future, and determine if Nvidia stock still represents a compelling opportunity heading into the company's highly anticipated financial report. Remarkable results After generating triple-digit revenue and profit growth for two consecutive fiscal years, growth inevitably slowed, and investors got the jitters. Despite tough year-over-year comps, Nvidia's results were still enviable. For its fiscal 2026 first quarter (ended April 27), Nvidia reported record revenue of $44.1 billion, which soared 69% year over year and 12% sequentially. This resulted in adjusted earnings per share (EPS) of $0.81, up 33%, but there's an asterisk on those numbers. Nvidia took a $4.5 billion writedown on H20 chips destined for China, because of the Trump administration's moratorium on AI chip sales in that country (which has since been lifted). Without that charge, EPS would have been $0.96, a 57% increase. Make no mistake: It was the continuing adoption of AI that drove the robust results, as revenue from Nvidia's data center segment climbed 73% to $39 billion, representing 89% of its total revenue. Management expects Nvidia's growth spurt to continue, albeit at a more moderate pace. For its fiscal 2026 second quarter (ended July 27), management is guiding for revenue of $45 billion, which would represent year-over-year growth of 50%. Wall Street is equally bullish, with analysts' consensus estimates calling for revenue of $45.68 billion and adjusted EPS of $1.00. While this would represent a minor slowing compared with last quarter's robust growth, it would still be remarkable nonetheless. Same customers, expanding opportunity The biggest concern among Nvidia investors is that the adoption of AI will hit a wall, but there's simply no evidence to back that assertion. In fact, all the available evidence suggests the proliferation of AI continues. Amazon Web Services, Microsoft Azure, and Alphabet 's Google Cloud, are collectively known as the "Big Three" in cloud computing, and each has recently revealed plans to increase infrastructure spending this year, beyond the already robust spending that was previously announced. Furthermore, most of that spending will be allocated to additional data centers to support the growing demand for AI -- most of which will run on Nvidia GPUs. In addition, Meta Platforms also announced that it was increasing its capital expenditure spending plans for the year. The totals are enlightening: Amazon: $118 billion, up from $100 billion. Microsoft: $100 billion, up from $80 billion. Alphabet: $85 billion, up from $75 billion. Meta: $69 billion, up from $62.5 billion. It's no coincidence that these four companies are also Nvidia's biggest customers. Add to that the resumption of H20 chip sales and China, and it appears clear that Nvidia's AI opportunity continues to expand. Should you buy the stock before Aug. 27? To be clear, I expect Nvidia stock to remain volatile, driven by the inevitable ebbs and flows of AI spending. That said, its success thus far has been undeniable. Over the past three years, the stock has gained 882% (as of this writing) but has also fallen as much as 37% -- so it isn't for the faint of heart. This helps illustrate one of the hallmarks of investing success: Treat buying stocks as partial ownership in a business, own stocks in the best companies out there, and commit to holding for at least three to five years. That takes us back to the main question: Should you buy Nvidia stock before Aug. 27? The unspoken question here is whether Nvidia stock will be up or down following the release of its highly anticipated quarterly report. Truth be told, I have no idea, nor does anyone else for that matter. My crystal ball has been on the blink for some time, but if I were in the mood to prognosticate, I would feel comfortable making several very vague predictions: Nvidia will announce yet another in a long and growing series of quarterly revenue records. Given the company's track record of exceeding expectations, I suspect it will beat analysts' consensus estimates, which are calling for sales of $45.68 billion -- which is slightly ahead of management's guidance of $45 billion -- and adjusted EPS of $1.00. Beyond that, it's anyone's guess, and my predictions could be way off base. That said, I'm still extremely confident that my investing thesis for Nvidia remains intact. The company's cutting-edge GPUs are still the gold standard, driving the AI revolution, and rivals have yet to challenge its position as the undisputed market leader or come up with a superior product. The specter of competition remains, as there's always the possibility that a technological innovation could steal Nvidia's thunder. Most experts agree that it's still early innings for AI, but there's no consensus about the size of the market. Even the most conservative estimates start at $1 trillion. Big Four accounting firm PwC estimates the total economic impact at $15.7 trillion between now and 2030. The truth is nobody knows for sure. Nvidia stock is currently selling for roughly 30 times next year's earnings. However, that premium is backed by the company's track record of innovation, industry-leading position, and history of growth. This underpins my confidence that the runway ahead is long. For those who believe that the AI revolution will play out over the next decade and Nvidia will maintain its position as the leading provider of AI chips, the answer is clear. We don't know what the stock will do between now and Aug. 27 and for long-term investors, that doesn't matter. We'll simply buckle up for the bumpy (and profitable) ride ahead. Should you invest $1,000 in Nvidia right now? Before you buy stock in Nvidia, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nvidia wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $624,823!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,064,820!* Now, it's worth noting Stock Advisor's total average return is 1,019% — a market-crushing outperformance compared to 178% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025
Globe and Mail
23 minutes ago
- Globe and Mail
The Smartest Dividend Stocks to Buy With $10,000 Right Now
Key Points Several strategic decisions United Parcel Service has made of late are starting to come together just as the world shakes off the last of the post-pandemic delivery and logistics lull. Shares of drugmaker Pfizer have been upended by price-control worries and a wind-down of its booming COVID-19 business. But there's reason to look for better days on the horizon. Defense contractor Lockheed Martin looks and seems vulnerable. The market's not seeing its future in quite the right light, though. 10 stocks we like better than Lockheed Martin › Are you looking to put a sizable chunk of cash to work generating investment income? Whether you intend to live on this income or reinvest it to bolster your portfolio's overall growth, there are several great dividend-paying options out there right now. Here's a closer look at three of your best bets at this time, not despite each stock's recent turbulence and mostly bearish drama but because of it. United Parcel Service You probably already know that United Parcel Service 's (NYSE: UPS) revenue dwindled after soaring during and because of the COVID-19 pandemic, taking a similar toll on the bottom line. Indeed, the delivery giant's business has been stagnant -- at best -- since 2022. Its second-quarter sales and income both fell on the order of 1% year over year, extending its anemic results in the meantime. The amount of business and pricing power that was in place just four years ago simply isn't there anymore. UPS stock's 63% pullback from its 2022 peak to yet another new multiyear low reached earlier this month, however, is overdone at the exact wrong time to price in such pessimism. Not every investor will immediately agree with this assessment. The threat of a lingering tariff war continues to threaten United Parcel Service's business following its post-pandemic slowdown. The company isn't exactly helping its stock either, opting not to offer any guidance with its recently released Q2 report, after which CEO Carol Tomé lamented during the quarterly earnings call that "for our sector, this remains a very unsettling time." There's an argument to be made, however, that all the worst-case scenario is now priced in at a time when things are on the verge of turning around. The decision to make fewer but more profitable deliveries has already been enacted, for instance. And the company has already cut $3.5 billion worth of annual overhead, with total yearly savings of $6 billion being targeted further down the road. It's just going to take a little more time to make and see the adjustment to such changes. The backdrop is still quite bullish in the meantime, though. An outlook from Mordor Intelligence suggests the global parcel delivery market is set to grow at an average annual pace of just over 5% through 2030, jibing with expectations from Global Market Insights. That's better growth than we've seen at any point since the wind-down of the coronavirus contagion. Newcomers will not only be plugging into UPS while its forward-looking yield stands at 7.4%, but while the stock's priced dirt cheap -- at only 13 times this year's analyst-expected per-share earnings of $6.64. It's not going to get much cheaper than that. Pfizer It's a tough time to be excited about owning any pharmaceutical stocks, but especially Pfizer (NYSE: PFE). Not only is the federal government looking to force drugmakers to offer better prices to its Medicare program, but Pfizer still hasn't restored the revenue it lost once the need for its COVID-19 vaccine and treatment evaporated in 2023. That's the chief reason shares have been more than halved since late 2021. Well, that and the fact that the company is technically dishing out more in dividends than it's earning while it's facing a handful of patent expirations in the foreseeable future. Just don't lose perspective here. On any of it. Take its underfunded dividend as an example. It's not actually underfunded. Last year's reported per-share earnings of $1.41 were less than the full-year dividend payout of $1.68 per share, but that figure reflected a one-time accounting charge. Stripping this expense out of the equation reinflates earnings to a more normalized figure of $3.11 per share, easily covering its dividend. Pfizer also has replacements in the works for all its COVID drugs that are less needed, as well as its drugs with patents set to expire in the foreseeable future. Vepdegestrant (for ER+/HER2- metastatic breast cancer) and sigvotatug vedotin (for metastatic non-small cell lung cancer) are both in late-stage trials now, for instance, as part of a developmental pipeline that consists of around 50 oncology drugs. Although none of these drugs are going to be approved and marketed in the immediate future, the company is aiming to launch at least eight new cancer drugs by 2030. The market could begin rewarding their eventual success much sooner, though. The company's also looking to enter the multibillion-dollar weight-loss market with its own GLP-1 receptor agonist, which is based on the same basic science as well-known semaglutide. And as for the threat of lower drug prices for Medicare-covered patients, don't read too much into it. This threat remains in permanent circulation and rarely causes as much trouble as feared. As BMO Capital Markets analyst Evan David Seigerman noted back in May, when President Donald Trump first ramped up his rhetoric on the matter, his plan "could be more rhetoric than actual implementable policy." In other words, it's more bark than bite. Don't be surprised to see Pfizer shares start climbing again once more investors start connecting all these dots, particularly given how their weakness has inflated the stock's forward-looking dividend yield to 7.2%. Lockheed Martin Finally, add defense contractor Lockheed Martin (NYSE: LMT) to your list of dividend stocks to buy with bigger amounts of capital while its forward-looking dividend yield is a respectable 3.1%. It's yet another victim of federal budget real and feared. In June, for instance, the U.S. Department of Defense halved its previous order of F-35 fighter jets (which account for more than one-fourth of Lockheed's annual revenue) for the government's fiscal year beginning in October. That followed March's news that the DoD chose Boeing rather than Lockheed to manufacture the next-generation F-47 fighter plane... a contract that could have been worth hundreds of billions of dollars over the course of many, many years. Meanwhile, support for Ukraine in its conflict against Russia appears to be waning, potentially crimping deliveries of new weaponry to the region. All told, Lockheed Martin shares are down more than 30% from October's peak and still testing new 52-week lows on these worries. . Once again, though, don't lose perspective. The U.S. military may not need as many F-35 fighter planes as it thought it would in the year ahead, nor does it want Lockheed-Martin to manufacture its next generation of fighter jets. It still needs much of Lockheed's weapons and military hardware, though, like its newly unveiled artificial intelligence-powered synthetic aperture radar (SAR) that facilitates airborne maritime surveillance or its new magnetic anomaly detection technology (capable of finding submerged submarines) for its Sikorsky MH-60R "Seahawk" maritime helicopters. And just last month, the U.S. Missile Defense Agency added another $2 billion to an $8.3 billion contract with Lockheed to provide it with terminal high-altitude area defense (THAAD) interceptor missiles. Sure, investors would love to see strong and sustained demand for the F-35, which generates maintenance revenue long after the purchase of the aircraft is completed. Shareholders would have also been thrilled to see the company win the F-47 contract to the same reason. Lockheed Martin still has a range of ways to monetize its military hardware know-how for the long haul, though. Let's also not forget that one of the few things the United States' two major political parties agree on is the need to fully fund the nation's ability to defend itself and its interests. Even in the face of economic uncertainty, the U.S. Senate's overseeing panel recently approved a defense budget of $852 billion for the upcoming year, up just a bit from this year's figure and extending a multiyear growth trend that isn't apt to slow anytime soon. Admittedly, Lockheed stock's 3.1% yield isn't huge. It's based on a dividend; however, that's now been raised for 22 consecutive years. So close to becoming dividend royalty, it's unlikely the company's going to stop raising its annual dividend payments now. Should you invest $1,000 in Lockheed Martin right now? Before you buy stock in Lockheed Martin, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Lockheed Martin wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $624,823!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,064,820!* Now, it's worth noting Stock Advisor's total average return is 1,019% — a market-crushing outperformance compared to 178% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025
National Post
23 minutes ago
- National Post
Venture Global Calcasieu Pass Receives Uprate Approval from U.S. Department of Energy
Article content ARLINGTON, Va. — Today, Venture Global, Inc. (NYSE: VG) received approval from the U.S. Department of Energy (DOE) for an uprate amendment to its Calcasieu Pass LNG project. The uprate approval increases Calcasieu Pass' permitted peak liquefaction capacity from 12.0 million tonnes per annum (MTPA) to 12.4 MTPA. Article content 'Venture Global thanks its regulators, including DOE, for their efforts in prioritizing and streamlining approvals for critical energy infrastructure projects. These multibillion dollar investments will be key as the United States strengthens global energy security and increases energy trade with our partners around the world,' said Venture Global CEO Mike Sabel. Article content Calcasieu Pass, Venture Global's first project, reached first LNG production in 2022 and began commercial operations in April 2025. The company's second facility, Plaquemines LNG, began LNG production in December 2024. Venture Global's third project, CP2, received DOE export authorization and FERC approval in March 2025 and May 2025, respectively, signed long-term sales and purchase agreements for all of Phase One, and commenced site work on the project. Article content About Venture Global Article content Venture Global is an American producer and exporter of low-cost U.S. liquefied natural gas (LNG) with over 100 MTPA of capacity in production, construction, or development. Venture Global began producing LNG from its first facility in 2022 and is now one of the largest LNG exporters in the United States. The company's vertically integrated business includes assets across the LNG supply chain including LNG production, natural gas transport, shipping and regasification. The company's first three projects, Calcasieu Pass, Plaquemines LNG, and CP2 LNG, are located in Louisiana along the Gulf of America. Venture Global is developing Carbon Capture and Sequestration projects at each of its LNG facilities. Article content Forward-looking Statements Article content This press release contains certain statements that may include 'forward-looking statements.' All statements, other than statements of historical or present facts or conditions, included herein are 'forward-looking statements.' Included among 'forward-looking statements' are, among other things, statements regarding Venture Global's business strategy, plans and objectives, including the use of proceeds from the offering. Venture Global believes that the expectations reflected in these 'forward-looking statements' are reasonable, they are inherently uncertain and involve a number of risks and uncertainties beyond Venture Global's control. In addition, assumptions may prove to be inaccurate. Actual results may differ materially from those anticipated or implied in 'forward-looking statements' as a result of a variety of factors. These 'forward-looking statements' speak only as of the date made, and other than as required by law, Venture Global undertakes no obligation to update or revise any 'forward-looking statement' or provide reasons why actual results may differ, whether as a result of new information, future events or otherwise. Article content Article content Article content Article content
